Life Science Hotlist

find selected Life Science companies in Stockholm, Sweden

Looking for investment opportunities? Book a meeting free of charge!

The Stockholm-Uppsala Life Science Investment Hotlist features a carefully selected list of investment cases from one of the world’s leading knowledge regions. Curated by Invest Stockholm , the list is a tool for investors focused on disruptive commercial innovation in life science. The hotlist is updated continuously so stay tuned. This project is supported by the European Union.

Category
Sub Category
  • Abera Bioscience - has developed next-generation bacterial and derived OMV vaccine delivery platforms that combine high-level multivalent antigen presentation with strong stimulation of the immune system.

    Go to website
  • Affibody - is a clinical stage biopharmaceutical company developing a portfolio of innovative drug projects based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

    Go to website
  • AlzeCure Biologics - Tailored cell-based therapies for CNS orphan disorders: A New Generation Biologics

  • AlzeCure Pharma - Develops innovative therapies for the treatment of Alzheimer ́s disease and related neurodegenerative disorders.

    Go to website
  • Athera - is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease.

    Go to website
  • BioLamina - Stem cell culturing made easy.

    Go to website
  • Biosync Technology - offers a wearable biofeedback system for stress management and lifestyle tracking in the daily environment. The system offers great potential in various applications e.g. cost savings by primary and secondary prevention of stress related diseases.

    Go to website
  • Biovica - Blood Assays for prognosis and monitoring of solid tumors.

    Go to website
  • Bonzun Health Information - offers pregnant women and expecting fathers high quality medical information and live chat with medical professionals. All in one app that will keep the pregnant woman and child safe.

    Go to website
  • Byon8 - has developed, AITOPYA, an unique A.I. platform for medical diagnostic support for physicians and other caregivers, where the patient is in focus and guided to register their health information (Anamnes). The result is a better accuracy in diagnosis and time savings.

    Go to website
  • Coala - Coala Life has developed and launched prize-winning, digital solutions enabling daily monitoring and analysis of your heart

    Go to website
  • C-sense - is a company offering intelligent sensors for a variety of applications. C-sense has developed C-nose, a multi-sensor electronic nose that can be used as a bomb-nose as well as in food control and medical diagnostics.

    Go to website
  • Cytacoat - CytaCoat’s platform technology provides a unique, universal and covalently coupled antibacterial coating for prevention of hospital acquired infections associated with the use of medical devices. The CytaCoat technology is active against several clinically relevant bacterial strains including multi drug resistant bacteria such as MRSA and ESBL.

    More About Cytacoat

    Target market

    Product/Business idea

    Product development and expansion

    Cytacoat.com
  • Diamyd Medical - develops therapies using our in-licensed substances GAD and GABA for the prevention or treatment of diabetes and other serious inflammatory diseases.

    Go to website
  • Double Bond Pharmaceutical - develops superior medicines by formulating the best known pharmaceutical compounds to target exactly the diseased organs.

    Go to website
  • DoubleStrand Bioinformatic - is a full service data science and bioinformatics company providing tailored solutions to the Biotech, Healthtech, Medtech and Pharma community. We create value from your data.

    Go to website
  • Empros Pharma - develops EMP16 an oral treatment for obesity and type 2 diabetes. Phase 2a trial demonstrates best-in-class safety profile and promising efficacy by innovative re-formulation of established drugs. Uniquely fast moving, low cost, low risk obesity project invites investors.

  • Eurocine Vaccines - develops Nasal vaccines – the natural way to protect against influenza and other diseases.

    Go to website
  • Glucox Biotech - Identifies and develops selective and specific Nox4 inhibitors with drug like properties.

    Go to website
  • Gnosco - has developed, Dermicus, an easy-to-use, flexible and secure decision support system for skin cancer and wounds. The app and platform is specifically aimed for communication between healthcare providers. More About Gnosco

    Go to website
  • Gradientech - Ultra-rapid sepsis treatment diagnosis - The QuickMIC™ diagnostic system under development generates phenotypic antibiotic susceptibility testing (AST) results from positive blood culture in as little as 2 hours

    Go to website
  • iCellate - can detect cancer before symptoms occus. It is achieved by capturing the single cells that spread the disease, the Circulating Tumor Cells (CTC).

    Go to website
  • Ilya Pharma - is developing the next generation biological drugs for treating wounds in skin and mucosa.

  • Immuneed - is an immuno-oncology company focusing on therapeutic vaccine development with a new targeting platform. Immuneed also offers a specialized service for advanced characterization of biopharmaceuticals in an ex vivo system, which can predict clinical outcome, thereby reducing the need for animal studies, and indicate clinical effects at an earlier stage.

    Go to website
  • InDex Pharmaceuticals - is a biopharmaceuticals company developing cobitolimod which is in late stage clinical development for ulcerative colitis with a novel mechanism of action that has shown clinical proof of concept, and is safe and well tolerated.

    Go to website
  • Invicta Medical - is a medical technology company that specializes in innovative therapies for sleep apnea and snoring.

  • IsletOne Therapeutics - proprietary clinical-stage off-the-shelf cell therapeutics within inflammation and autoimmunity, combined with an extensive pipeline of promising pre-clinical projects.

    Go to website
  • Lexplore - offers a completely new non-invasive screening method, enabling early, rapid, reliable and objective detection of people at risk of Parkinson’s and Alzheimer’s disease.

    Go to website
  • Linkura - prevents stress related disease using ECG wearables and online coaching. "Listen to your heart."

  • Lokon Pharma - developing immunostimulatory gene therapy for cancer using oncolytic viruses.

    Go to website
  • Lyfepond - is a one-stop shop for patients and dependants, where they receive support in their diagnose through qualified patient support programs, contact with industry, other patients and a marketplace for third-party providers of curative, relieving and health promoting products and services. Lyfepond is the first integrator in the fast-growing eHealth market.

    Go to website
  • Mando Group - A consumer version of an evidence based bio feedback device, used successfully to treat eating disorders for twenty years, has proven effective in weight loss.

    Go to website
  • Med Universe - patient case engagement cloud-based platform offered to the life science industry as SaaS, to effectively inform, educate and engage health care professionals about new treatments, therapies and devices via digital patient cases.

    Go to website
  • MediCheck - provides people with a shortcut to medical specialists, making better use of society’s medical knowledge and delivering it to more people in need.

    Go to website
  • MediTuner - offers the first clinically validated mobile platform to standardize asthma self-management for patients and healthcare providers.

  • Mimerse - create evidence based automatic psychological treatments in collaboration with leading researchers. They are on a mission to solve the world’s mental health problem and have recently launched their first product to Samsung Gear VR.

    Go to website
  • MindApps - is developing apps in the area of Mental Health. Has developed the market leading app The Mindfulness App and is about to convert the app to a subscription model. Up till today the app has more than 1 million downloads. Under development is also; “MindGym” a digital platform accessible from smart phones, tablets and computers that offer courses, programs and modules within the area of mindfulness and health in its wider sense

  • NeoDynamics - offers new technology biopsy system for improved diagnosis of cancer patients.

    Go to website
  • Pelago Bioscience - is established to accelerate the use and benefits of the patented CETSA® method in Drug Discovery and Development. Our focus is to deliver physiologically relevant high quality Target Engagement data to customers and collaborators enabling them to develop better and more efficacious new drugs faster.

    Go to website
  • Pilloxa - develops a patient-centric adherence platform. We are currently launching our first product in the form of a smart pillbox with a connected mobile application in order to facilitate medication for the smartphone generation.

    Go to website
  • Qinematic - suite of software enables a gaming sensor to record posture, movement and balance using 3D video. The end user is given instant animated feedback. A health professional can quickly and easily analyze performance, generate reports, for better decision making and monitor progress. Testing is automated and takes just a few minutes.

    Go to website
  • Scandinavian Biopharma - is a Swedish research-based biotech company specialist in marketing and sales of specialty pharma products to the Nordic market and Baltic States. Research and development is mainly focused on development of the first vaccine in the world protecting against diarrhea caused by ETEC in collaboration with PATH Vaccine Solutions and University of Gothenburg

    Go to website
  • ScioReality - cost-efficient training for health care professionals using virtual reality.

    Go to website
  • SensAbues - offers a breath test for drugs, metabolites and biomarkers. This is a newly discovered and proprietary procedure for the non-invasive collection, detection and identification of substances such as performance enhancing drugs used in sports (stimulants), drugs of abuse (narcotics), therapeutic drugs (antibiotics) as well as metabolomics and biomarkers.

    Go to website
  • Senzime - develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs.

    Go to website
  • Shim - is an evidence-based chatbot that helps users reduce stress and increase emotional well-being. The conversational UI, the low effort required to generate positive emotions and the social aspects makes Shim a better candidate to turn emotional well-being into a true mass market compared to its competitor.

    Go to website
  • Sigrid Therapeutics - has developed a breakthrough medical device, SiPore15, for the treatment of cardiovascular and metabolic risk factors such as elevated blood sugar and blood fat in prediabetic and type 2 diabetic patients.

    Go to website
  • Single Technologies - develops a technology concept that enables high-resolution 3D videos of molecules, living cells and tissue.

    Go to website
  • SinSa Labs - bioengineers Superdrugs to fight the world’s Superbugs.

  • Sprint Bioscience - Sprint Bioscience develops innovative drugs focused on cancer and metabolism.

    Go to website
  • SymCel Sverige - measure life and death of cells and bacteria through direct metabolic readout in label free cell based assays.

    Go to website
  • Xbrane Biopharma - develops pioneering high demand complex generics with world leading expertise and proprietary high-yield protein expression technology.

    Go to website
  • XSpray - Specializes in optimizing the performance of challenging drug substances with the RightSize technology platform. Focused on improving targeted oral anticancer agents, foremost protein kinase inhibitors.

    Go to website